Nasdaq Files Form 25 to Delist Pacira BioSciences Common Stock
Nasdaq filed a Form 25 with the SEC on Nov. 17, 2026, to remove Pacira BioSciences common stock from listing and registration.
What happened
Nasdaq Stock Market LLC filed a Form 25 with the Securities and Exchange Commission on Nov. 17, 2026, to strike Pacira BioSciences, Inc.'s common stock from listing and registration on the exchange, according to the filing.
The filing identifies Pacira BioSciences as the issuer, with principal executive offices at 5 Sylvan Way, Suite 125, Parsippany, New Jersey. The security covered is the company's common stock. The form was signed by Tara Petta, an assistant vice president at Nasdaq.
Pacira is a pharmaceutical company; its ticker is PCRX. The filing does not state why the shares are being removed from the exchange, and the provided sources do not explain the reason.
The filing
The Form 25 is titled 'Notification of Removal from Listing and/or Registration under Section 12(b) of the Securities Exchange Act of 1934.' It is the mechanism by which a security is formally removed from an exchange's listing list and from the registration tied to that listing.
The form includes checkboxes for the specific rule provision the exchange relied on. The text as provided does not indicate which box was checked, so the filing does not show whether the removal was initiated by the issuer or by Nasdaq.
The filing carries a Commission File Number of 001-35060, which is the identifier the SEC assigned Pacira when it registered the class of securities.
What this means
A Form 25 is the formal notice that a security is being taken off an exchange. It can be filed by the exchange or by the company, and it is not the same as a company simply choosing to move to another exchange — the filing does not say which case applies here.
This filing concerns common stock, the ordinary equity shares that trade under the ticker PCRX. That distinguishes it from a Form 25 covering debt securities such as notes or bonds that are being repaid at maturity, which is routine housekeeping. A delisting of common stock affects the shareholders who own the equity.
Once a Form 25 is filed, the delisting typically becomes effective a set number of days later under SEC rules, and the stock no longer trades on Nasdaq. The filing does not state the effective date or say where, if anywhere, the shares will trade afterward.
Sources
- 25-NSE filed 2026-11-17
- Daily price history
Information summarized by AI from the sources listed above. May contain errors — informational only, not investment advice.